Lexaria Bioscience Corp (NASDAQ: LEXX) has announced the signing of an advertising and media agreement for digital marketing and media buys with SRAX Inc. CEO of...
Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces that the company’s name features in an editorial published by NetworkNewsWire, a trusted brand within the InvestorBrandNetwork. In addition,...
Lexaria Bioscience Corp (NASDAQ: LEXX) has released partial results from HYPER-H12-1 human clinical trial evaluating DehhydraTech processed CBD as a potential hypertension application. Partial results linked...
Lexaria Bioscience Corp (NASDAQ: LEXX) announced an expansion of its intellectual property portfolio. The news comes after the global innovator in drug delivery platforms was granted...